MedPath

ASAL DEXMEDETOMIDINE FOR SEDATION DURING ENDOSCOPIC RETROGRADE PANCREATOGRAPHY-A NOVEL ROUTE FOR NOT SO NOVEL DRUG

Not Applicable
Completed
Conditions
Health Condition 1: null- POSTED FOR ELECTIVE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Registration Number
CTRI/2018/04/013308
Lead Sponsor
MS RAMAIAH MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

American Society of Anesthesiologists Physical Status (ASAPS) Grade I, II and III.

Exclusion Criteria

1.Pregnancy

2.Patient refusal.

3.Patients with evidence of arrhythmias and Obstructive Sleep Apnoea.

4.Body Mass Index(BMI) >35kg/m2

5. Chronic sedative use.

6.Known psychiatric illness.

7.Allergy to any of the above mentioned drugs used in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to access the reduction in consumption of primary drugs at end of procedureTimepoint: time calculated from insertion of scope till its removal
Secondary Outcome Measures
NameTimeMethod
to access the sedation score using OAA/S scaleTimepoint: post instillation every 15 minutes for 1 hour and post procedure evey 15 minutes for half an hour
© Copyright 2025. All Rights Reserved by MedPath